Cargando…

Hydrocortisone malabsorption due to polyethylene glycols (Macrogol 3350) in a girl with congenital adrenal insufficiency

BACKGROUND: Primary adrenal insufficiency is relatively rare in children and, if unrecognized, may present with cardiovascular collapse, making it a potentially life-threatening entity. CASE PRESENTATION: The proposita, 11 months old of age, was admitted for lethargy and severe dehydration. Blood pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stagi, Stefano, Del Greco, Paolo, Ricci, Franco, Iurato, Chiara, Poggi, Giovanni, Seminara, Salvatore, de Martino, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422474/ https://www.ncbi.nlm.nih.gov/pubmed/25255796 http://dx.doi.org/10.1186/s13052-014-0078-2

Ejemplares similares

Polyethylene Glycol 3350 With Electrolytes Versus Polyethylene Glycol 4000 for Constipation: A Randomized, Controlled Trial
por: Bekkali, Noor L.H., et al.
Publicado: (2018)

Antifibrotic preventive effect of polyethylene glycol (PEG) 3350 in methotrexateinduced hepatoxicity model
por: Acar, Hüseyin, et al.
Publicado: (2022)

Colorectal Transit and Volume During Treatment With Prolonged-release Oxycodone/Naloxone Versus Oxycodone Plus Macrogol 3350
por: Poulsen, Jakob L, et al.
Publicado: (2018)

Macrogol (polyethylene glycol) laxatives in children with functional constipation and faecal impaction: a systematic review
por: Candy, D, et al.
Publicado: (2009)

Safety of polyethylene glycol 3350 solution in chronic constipation: randomized, placebo-controlled trial
por: McGraw, Thomas
Publicado: (2016)

Polyethylene Glycol 3350 Crystal Nephropathy in Association With Glomerular Mesangial Immunoglobin A Deposition
por: Aly, Rasha, et al.
Publicado: (2022)

Urticaria as a Rare Side Effect of Polyethylene Glycol-3350 in a Child: Case Report
por: Gökay, Sinem Sari, et al.
Publicado: (2018)

Using Polyethylene Glycol 3350 Plus Electrolytes in Constipated Hemodialysis Patients: A Case Series
por: Endo, Hiroyuki, et al.
Publicado: (2020)

Macrogol (polyethylene glycol) 4000 without electrolytes in the symptomatic treatment of chronic constipation: a profile of its use
por: Lyseng-Williamson, Katherine A.
Publicado: (2018)

Clinical efficacy and safety of polyethylene glycol 3350 versus liquid paraffin in the treatment of pediatric functional constipation
por: Rafati, MR., et al.
Publicado: (2011)

Polyethylene glycol 3350 plus electrolytes for pediatric chronic constipation: An open‐label clinical study in Japan
por: Gondo, Mayuko, et al.
Publicado: (2020)

Utilisation and Safety of Polyethylene Glycol 3350 With Electrolytes in Children Under 2 Years: A Retrospective Cohort
por: Roy, Debabrata, et al.
Publicado: (2021)

Polyethylene Glycol 3350 in the Treatment of Chronic Idiopathic Constipation: Post hoc Analysis Using FDA Endpoints
por: Menees, Stacy B., et al.
Publicado: (2022)

Correction to: Macrogol (polyethylene glycol) 4000 without electrolytes in the symptomatic treatment of chronic constipation: a profile of its use
por: Lyseng-Williamson, Katherine A.
Publicado: (2018)

Urticaria due to polyethylene glycol-3350 and electrolytes for oral solution in a patient with jejunal nodular lymphoid hyperplasia
por: Zhang, Hongfeng, et al.
Publicado: (2015)

Efficacy and Safety of Combined Oral and Enema Therapy Using Polyethylene Glycol 3350-Electrolyte for Disimpaction in Pediatric Constipation
por: Yoo, Taeyeon, et al.
Publicado: (2017)

Early Metabolic Benefits of Switching Hydrocortisone to Modified Release Hydrocortisone in Adult Adrenal Insufficiency
por: Bannon, Christopher A. M., et al.
Publicado: (2021)

1-day bowel preparation with polyethylene glycol 3350 is as effective and safe as a 3-day preparation for colonoscopy in children
por: Sorser, Serge A, et al.
Publicado: (2014)

High-dose polyethylene glycol-3350 and gatorade solutions for patients with previous inadequate bowel preparations for colonoscopy are safe and effective
por: Gerard, David P., et al.
Publicado: (2023)

Bowel cleansing efficacy of 1 L NER1006 versus macrogol and 3 L polyethylene glycol using split‐dose administration
por: Sinh, Priya, et al.
Publicado: (2022)

Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350
por: Fortuny, Joan, et al.
Publicado: (2019)

Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency
por: Guarnotta, V, et al.
Publicado: (2019)

Methylprednisolone/peg-3350/sodium-chloride/sodium-bicarbonate/potassium-chloride/phenoxymethylpenicillin: Anaphylaxis to the polyethylene glycol (PEG) excipients : 2 case reports
Publicado: (2022)

Metabolic Effects of Cortisone Acetate vs Hydrocortisone in Patients With Secondary Adrenal Insufficiency
por: Ekstrand, Elise, et al.
Publicado: (2020)

Bone safety of dual-release hydrocortisone in patients with autoimmune primary adrenal insufficiency
por: Bioletto, Fabio, et al.
Publicado: (2023)

Exenatide Alters Absorption of Hydrocortisone in a Diabetic Patient With Panhypopituitarism: Iatrogenic Adrenal Insufficiency
por: Fujita, Yukari, et al.
Publicado: (2013)

Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency
por: Quinkler, Marcus, et al.
Publicado: (2016)

Two Girls With Adrenal Insufficiency and Failing Gonads
por: Poon, Sarah Wing-Yiu, et al.
Publicado: (2023)

Tissue Glucocorticoid Metabolism in Adrenal Insufficiency: A Prospective Study of Dual-release Hydrocortisone Therapy
por: Dineen, Rosemary A, et al.
Publicado: (2023)

Polyethylene glycol 3350 plus electrolytes for chronic constipation: a 2-week, randomized, double-blind, placebo-controlled study with a 52-week open-label extension
por: Nakajima, Atsushi, et al.
Publicado: (2019)

In Vitro Evaluation of Cocoa Pod Husk Pectin as a Carrier for Chronodelivery of Hydrocortisone Intended for Adrenal Insufficiency
por: Adi-Dako, Ofosua, et al.
Publicado: (2017)

SAT-391 Perioperative Glucocorticoid Therapy for Patients with Adrenal Insufficiency: Dosing Based on Hydrocortisone Pharmacokinetic Data
por: Rahhal, Marie-Noel, et al.
Publicado: (2019)

Dual-release hydrocortisone improves hepatic steatosis in patients with secondary adrenal insufficiency: a real-life study
por: Guarnotta, Valentina, et al.
Publicado: (2019)

A Prospective Study of Children Aged 0–8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules
por: Neumann, Uta, et al.
Publicado: (2020)

Effects of the therapy shift from cortisone acetate to modified-release hydrocortisone in a group of patients with adrenal insufficiency
por: Frigerio, Sofia, et al.
Publicado: (2023)

Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency
por: Gasco, V., et al.
Publicado: (2022)

SPIE Technical Conference 3350 on Astronomical Interferometry
por: Reasenberg, R, et al.
Publicado: (1998)

Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
por: Merke, Deborah P, et al.
Publicado: (2021)

Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency
por: Nilsson, A G, et al.
Publicado: (2014)

SAT-381 Cognitive Function and Quality of Sleep in Patients with Adrenal Insufficiency May Benefit by Therapy with Dual-Release Hydrocortisone
por: Krekeler, Clarissa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_us0eb9anbbb3lkhdp7i35kdp47